Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials ...Middle East

PR Newswire - Economy
Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials
SAN DIEGO, March 19, 2024 /PRNewswire/ -- Tempo Therapeutics, Inc ("Tempo") a leading innovator in tissue engineering and regenerative medicine, today announced the successful completion of its $12 million Series A equity financing round, led by Galaxy-Sirius Partners and Johnson &...

Hence then, the article about tempo therapeutics secures series a financing to advance cutting edge tissue scaffold products into clinical trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before hour & 23 minute